Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV003237318 | SCV003935867 | uncertain significance | Rubinstein-Taybi syndrome due to CREBBP mutations | 2022-10-19 | no assertion criteria provided | research | |
Prevention |
RCV004741578 | SCV005341773 | uncertain significance | CREBBP-related disorder | 2024-09-09 | no assertion criteria provided | clinical testing | The CREBBP c.4571A>G variant is predicted to result in the amino acid substitution p.Lys1524Arg. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |